## Answer
(model generated chain of thought explanation)

Given the patient's presentation of acute ST elevation myocardial infarction (STEMI) with a new onset of chest pain radiating to the shoulder, we need to consider the most effective treatment options for this condition.

Firstly, the patient has already received multiple doses of sublingual nitroglycerin, which is typically used to relieve angina symptoms by dilating blood vessels and reducing myocardial oxygen demand. However, in this case, the pain has not subsided, suggesting that the STEMI may be more severe than initially thought.

The additional S4 sound heard on cardiac auscultation suggests left ventricular hypertrophy (LVH), which is a common finding in patients with chronic coronary artery disease. This LVH can lead to increased myocardial oxygen demand and contribute to the development of acute ST elevation myocardial infarction.

Considering the patient's age, the presence of LVH, and the new onset of chest pain radiating to the shoulder, we need to consider treatment options that are both effective in reducing myocardial oxygen demand and minimizing the risk of further cardiac complications.

Beta blockers (A) can help reduce myocardial oxygen demand by decreasing heart rate and contractility. However, they may not be sufficient on their own to manage acute STEMI with LVH.

Clopidogrel (B) is an antiplatelet agent that can help prevent further clot formation in patients with acute coronary syndromes. While it is a crucial component of long-term cardiovascular management, it may not be the most effective option for this patient given the presence of LVH and the need to rapidly reduce myocardial oxygen demand.

Thrombolytics (C) are typically reserved for patients who have developed a new onset of symptoms within 12-24 hours of symptom onset or in whom there is evidence of cardiac rupture. Given the patient's presentation, thrombolysis may not be the most appropriate initial treatment.

Percutaneous coronary intervention (D), also known as percutaneous coronary angioplasty (PCI), is a minimally invasive procedure that involves using a balloon to open up blocked coronary arteries and restore blood flow to the heart muscle. Given the patient's presentation of STEMI with LVH, PCI is likely to be the most beneficial treatment option.

Therefore, the best answer is D.